Diminazene Aceturate NEW
| Price | $42 |
| Package | 100mg |
| Min. Order: | |
| Supply Ability: | 10g |
| Update Time: | 2025-04-29 |
Product Details
| Product Name: Diminazene Aceturate | CAS No.: 908-54-3 |
| Purity: 98.78% | Supply Ability: 10g |
| Release date: 2025/04/29 |
Product Introduction
Bioactivity
| Name | Diminazene Aceturate |
| Description | Diminazene is a trypanocidal agent. |
| In vitro | Administering 7 mg/kg, i.m. of Diminazene aceturate effectively clears parasites from the bloodstream of infected dogs. An initial treatment dose of 3.5 mg/kg of Diminazene aceturate significantly alleviates T. evansi infection in horses and mules, with parasites being eliminated from the peripheral blood within 1-7 days and 1-14 days, respectively. |
| In vivo | Transport of [3H] diminazene is substantially inhibited by pentamidine and adenosine, with Ki values of 0.21 μM and 0.25 μM, respectively. Notably, [3H] diminazene accumulates in yeast cells expressing TbAT1 at a rate of 0.0083 pmol/10^7 cells/s when treated with 2.5 μM of the radioactive compound, and this accumulation is completely suppressed by 1 mM of unlabeled Diminazene Aceturate. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Solubility Information | H2O : 92 mg/mL (178.46 mM), Sonication is recommended. Ethanol : < 1 mg/mL (insoluble or slightly soluble) DMSO : 1 mg/mL (1.94 mM), Sonication is recommended. |
| Keywords | Trypsin-1 | SerineProtease | Serine Protease | QacR | Peroxiredoxin-5 | Parasite | Inhibitor | inhibit | Diminazene diaceturate | Diminazene Aceturate | Diminazene | Angiotensin-converting Enzyme (ACE) |
| Inhibitors Related | Picaridin | Kaempferol | Kojic acid | Urethane | Hydroxychloroquine | Metronidazole | Nitazoxanide | Doxycycline | Chloroquine phosphate | Diethyltoluamide | Artemisinin | DL-Methionine |
| Related Compound Libraries | Anti-Parasitic Compound Library | Bioactive Compound Library | Approved Drug Library | Protease Inhibitor Library | Drug Repurposing Compound Library | Endocrinology-Hormone Compound Library | Immunology/Inflammation Compound Library | Anti-Aging Compound Library | Bioactive Compounds Library Max | Anti-COVID-19 Compound Library | Anti-Infection Compound Library | Anti-Hypertension Compound Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $42.00/100mg |
VIP5Y
|
TargetMol Chemicals Inc.
|
2025-04-28 | |
| $0.00/1kg |
VIP4Y
|
WUHAN FORTUNA CHEMICAL CO., LTD
|
2024-05-18 | |
| $100.00/1bag |
Hebei Fengqiang Trading Co., LTD
|
2023-08-11 | ||
| $1.10/1g |
VIP5Y
|
Dideu Industries Group Limited
|
2021-06-18 | |
| $0.00/1Kg |
VIP6Y
|
Shaanxi Dideu Medichem Co. Ltd
|
2020-04-27 | |
| $9.80/1KG |
VIP6Y
|
Career Henan Chemical Co
|
2020-01-09 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, USA
INQUIRY